2030 Pharmaceutical Supply Chain 
Frost & Sullivan Manufacturing
APRIL 2, 2025
Held in New York during March 17-20, 2025, the event focused on pharmaceutical innovation, industry outlook, capacity expansion, and supply chain resilience, driven by the increasing digitization of drug development and manufacturing. trillion in 2024, is expected to grow at a 7% CAGR through 2030.
Gary Mintchell
MARCH 25, 2024
A speaker at a Siemens event maybe five years ago extolled the future of pharmaceutical supply chain data through blockchain. Global blockchain platform and services revenue is set to grow from $12 billion in 2023 to $291 billion in 2030. Dixon provides a good overview of the current status of blockchain.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Manufacturer's Monthly
AUGUST 21, 2022
The increase came as companies weathered the disruption wrought by COVID-19, however ongoing pressures on workforces, supply chains and production costs pose a challenge to plans to secure food and grocery manufacturing’s future as a key growth industry. . Domestically, human pharmaceutical products turnover rose 50 per cent to $2.21
Manufacturer's Monthly
SEPTEMBER 20, 2023
The co-funded projects involve total investments of more than $16 million, with the businesses operating in a variety of manufacturing sectors including food and beverage, pharmaceuticals, mining, construction, and machinery and equipment.
Canadian Manufacturing
SEPTEMBER 6, 2022
trillion by 2030 from $2.30 “With higher levels of halal trade and Islamic finance potentially accelerating infrastructure development, the halal economy is poised to become more integrated with global trade and supply chains,” said Neha Anna Thomas, Senior Economist at Frost & Sullivan. trillion in 2020.
Frost & Sullivan Manufacturing
SEPTEMBER 6, 2022
trillion by 2030 from $2.30 With higher levels of halal trade and Islamic finance potentially accelerating infrastructure development, the halal economy is poised to become more integrated with global trade and supply chains,” said Neha Anna Thomas, Senior Economist at Frost & Sullivan. trillion in 2020.
AU Manufacturing
SEPTEMBER 22, 2022
The pharmaceuticals we and our partners develop rely on the production of isotopes from this generator. AdvanCell is an Australian company dedicated to changing the course of cancer treatment. This technology enables a revolutionary treatment called Targeted Alpha Therapy.
Expert insights. Personalized for you.
52 
Let's personalize your content